These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9035229)

  • 1. Mortality studies and the effectiveness of drugs in long-term treatment.
    Ahrens B
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):57-61. PubMed ID: 9035229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
    Roick C; Ahrens B; Becker T
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S32-40. PubMed ID: 11533905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.
    Kallner G; Lindelius R; Petterson U; Stockman O; Tham A
    Pharmacopsychiatry; 2000 Jan; 33(1):8-13. PubMed ID: 10721878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
    Licht RW; Vestergaard P; Brodersen A
    Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium treatment present and future.
    Gomez GE
    J Psychosoc Nurs Ment Health Serv; 2001 Aug; 39(8):31-7. PubMed ID: 11503429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).
    Linden M; Baier D; Beitinger H; Kohnen R; Osterheider M; Philipp M; Reimitz DE; Schaaf B; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):65-70. PubMed ID: 9035231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients.
    Nilsson A
    Pharmacopsychiatry; 1995 Jan; 28(1):8-13. PubMed ID: 7746844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somnambulistic-like behaviour in patients attending a lithium clinic.
    Landry P; Warnes H; Nielsen T; Montplaisir J
    Int Clin Psychopharmacol; 1999 May; 14(3):173-5. PubMed ID: 10435770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic and health outcome comparison of lithium and divalproex in a VA geriatric nursing home population: influence of drug-related morbidity on total cost of treatment.
    Conney J; Kaston B
    Am J Manag Care; 1999 Feb; 5(2):197-204. PubMed ID: 10346515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva for monitoring of patients with primary affective disorders.
    Ben-Aryeh H; Laor R; Szargel R; Gutman D; Naon H; Pascal M; Hefetz A
    Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.